List of Tables

Table 2.1: Impact Analysis of Market Drivers
Table 2.2: Impact Analysis of Market Restraints
Table 4.1: Registration Criteria for IVD Medical Devices as per the NMPA

List of Figures

Figure 1: Precision Medicine: A Multi-Faceted Approach to Patient Care
Figure 2: Impact of Market Drivers and Market Restraints on the China Precision Medicine Market
Figure 3: China Precision Medicine Market Snapshot
Figure 4: Dominating Segments of the China Precision Medicine Market, 2018 and 2029
Figure 5: China Precision Medicine Market (by Applied Sciences), 2018 and 2029
Figure 6: China Precision Medicine Market (by DHIT), 2018 and 2029
Figure 7: China Precision Medicine Market (by Application), 2018 and 2029
Figure 1.1: Precision Medicine: Remodeling the One-Size-Fits-All Theory to Individually Tailored Therapy
Figure 1.2: Classification of China Precision Medicine Market
Figure 1.3: China Precision Medicine Market, 2018-2029
Figure 2.1: Decreasing Cost and Increasing Output (TB) of Genome Sequencing (2009-2025)
Figure 2.2: Population Representation in GWAS Studies (2016)
Figure 3.1: Share of Key Developments and Strategies, January 2016 – June 2019
Figure 3 2: Synergistic Activities Share (by Company), January 2016 – June 2019
Figure 3.3: Product Approvals Share (by Company), January 2016 – June 2019
Figure 3.4: Business Expansion and Funding Activities Share (by Company), January 2016 – June 2019
Figure 3.5: Market Share Analysis for the China Precision Medicine Market, 2017
Figure 3.6: Market Share Analysis for the China Precision Medicine Market, 2018
Figure 3.7: Growth Share Matrix for China Precision Medicine Market (by Companies), 2018
Figure 4.1: Medical Device Registration in China (2017)
Figure 4.2: Class III Medical Device Registration in China (2017)
Figure 5.1: China Precision Medicine Market (by Ecosystem)
Figure 5.2: China Precision Medicine Market (by Ecosystem), 2018 and 2029
Figure 5.3: China Precision Medicine Market (by Applied Sciences), 2018-2029
Figure 5.4: China Precision Medicine Market (by Applied Sciences Types), 2018 and 2029
Figure 5.5: China Precision Medicine Market (by Genomics), 2018-2029
Figure 5.6: China Precision Medicine Market (by Genomics, by Technology), 2018 and 2029
Figure 5.7: China Precision Medicine Market (by Genomics, by PCR), 2018-2029
Figure 5.8: China Precision Medicine Market (by Genomics, by PCR Product Types), 2018 and 2029
Figure 5.9: China Precision Medicine Market (by Genomics, by PCR End User), 2018 and 2029
Figure 5.10: China Precision Medicine Market (by Genomics, by NGS), 2018-2029
Figure 5.11: China Precision Medicine Market (by Genomics, by NGS Product Types), 2018 and 2029
Figure 5.12: China Precision Medicine Market (by Genomics, by NGS Technology), 2018 and 2029
Figure 5.13: China Precision Medicine Market (by Genomics, by NGS End User), 2018 and 2029
Figure 5.14: China Precision Medicine Market (by Genomics, by Genome Editing), 2018-2029
Figure 5.15: China Precision Medicine Market (by Genomics, by Genome Editing Product Types), 2018 and 2029
Figure 5.16: China Precision Medicine Market (by Genomics, by Genome Editing End Users), 2018 and 2029
Figure 5.17: China Precision Medicine Market (by Genomics, by Other Technologies), 2018-2029
Figure 5.18: China Precision Medicine Market (by Pharmacogenomics), 2018-2029
Figure 5.19: China Precision Medicine Market (by Pharmacogenomics Services), 2018-2029
Figure 5.20: China Precision Medicine Market (by Pharmacogenomics End Users), 2018-2029
Figure 5.21: China Precision Medicine Market (by Other Applied Sciences), 2018-2029
Figure 5.22: China Precision Medicine Market (by Precision Therapeutics), 2018-2029
Figure 5.23: China Precision Medicine Market (by Precision Therapeutics), 2018 and 2029
Figure 5.24: China Precision Medicine Market (by Clinical Trials), 2018-2029
Figure 5.25: China Precision Medicine Market (by Cell Therapy), 2018-2029
Figure 5.26: China Precision Medicine Market (by Drug Discovery and Research), 2018-2029
Figure 5.27: China Precision Medicine Market (by Gene Therapy), 2018-2029
Figure 5.28: China Precision Medicine Market (by DHIT), 2018-2029
Figure 5.29: China Precision Medicine Market (by DHIT), 2018 and 2029
Figure 5.30: China Precision Medicine Market (by DHIT End Users), 2018-2029
Figure 5.31: China Precision Medicine Market (by CDSS), 2018-2029
Figure 5.32: China Precision Medicine Market (by Big Data Analytics), 2018-2029
Figure 5.33: China Precision Medicine Market (by IT Infrastructure), 2018-2029
Figure 5.34: China Precision Medicine Market (by IT Infrastructure Types), 2018-2029
Figure 5.35: China Precision Medicine Market (by Genome Informatics), 2018-2029
Figure 5.36: China Precision Medicine Market (by Genome Informatics Product Types), 2018 and 2029
Figure 5.37: China Precision Medicine Market (by In-silico Informatics), 2018-2029
Figure 5.38: China Precision Medicine Market (by Mobile Health), 2018-2029
Figure 5.39: China Precision Medicine Market (by Precision Diagnostics), 2018-2029
Figure 5.40: China Precision Medicine Market (by Precision Diagnostics), 2018 and 2029
Figure 5.41: China Precision Medicine Market (by Molecular Diagnostics), 2018-2029
Figure 5.42: China Precision Medicine Market (by Molecular Diagnostic Types), 2018 and 2029
Figure 5.43: China Precision Medicine Market (by NIPT), 2018-2029
Figure 5.44: China Precision Medicine Market (by NIPT Platforms), 2018 and 2029
Figure 5.45: China Precision Medicine Market (by Companion Diagnostics), 2018-2029
Figure 5.46: China Precision Medicine Market (by Companion Diagnostics Technologies), 2018 and 2029
Figure 5.47: China Precision Medicine Market (by Companion Diagnostics Indications), 2018 and 2029
Figure 5.48: China Precision Medicine Market (by Liquid Biopsy), 2018-2029
Figure 5.49: China Precision Medicine Market (by Liquid Biopsy Indications), 2018 and 2029
Figure 5.50: China Precision Medicine Market (by Other Molecular Diagnostics), 2018-2029
Figure 5.51: China Precision Medicine Market (by Other Molecular Diagnostics), 2018 and 2029
Figure 5.52: China Precision Medicine Market (by Medical Imaging), 2018-2029
Figure 5.53: China Precision Medicine Market (by Medical Imaging Types), 2018 and 2029
Figure 5.54: China Precision Medicine Market (by Image Analytics), 2018-2029
Figure 5.55: China Precision Medicine Market (by Imaging CAD), 2018-2029
Figure 6.1: China Precision Medicine Market (by Application)
Figure 6.2: China Precision Medicine Market (by Application), 2018 and 2029
Figure 6.3: China Precision Medicine Market (by Oncology), 2018-2029
Figure 6.4: China Precision Medicine Market (by Infectious Diseases), 2018-2029
Figure 6.5: China Precision Medicine Market (by Neurology/Psychiatry), 2018-2029
Figure 6.6: China Precision Medicine Market (by Lifestyle and Endocrinology), 2018-2029
Figure 6.7: China Precision Medicine Market (by Cardiology), 2018-2029
Figure 6.8: China Precision Medicine Market (by Gastroenterology), 2018-2029
Figure 6.9: China Precision Medicine Market (by Other Applications), 2018-2029
Figure 7.1: Total Number of Companies Profiled
Figure 7.2: Agena Biosciences, Inc.: Overall Product Portfolio
Figure 7.3: Agena Biosciences, Inc.: SWOT Analysis
Figure 7.4: Agilent Technologies, Inc.: Overall Product Portfolio
Figure 7.5: Agilent Technologies, Inc.: Overall Financials, 2016-2018
Figure 7.6: Agilent Technologies, Inc.: Revenue (by Segment), 2016-2018
Figure 7.7: Agilent Technologies, Inc.: Revenue (by Region), 2016-2018
Figure 7.8: Agilent Technologies, Inc.: R&D Expenditure, 2016-2018
Figure 7.9: Agilent Technologies, Inc.: SWOT Analysis
Figure 7.10: Product Portfolio: Berry Genomics Co., Ltd
Figure 7.11: Berry Genomics Co., Ltd: Overall Financials, 2017-2018
Figure 7.12: Berry Genomics Co., Ltd: Revenue (by Segment), 2017-2018
Figure 7.13: Berry Genomics Co., Ltd: Revenue (by Region), 2017-2018
Figure 7.14: Berry Genomics Co., Ltd: SWOT Analysis
Figure 7.15: Beijing Genomics Institute (BGI) Genomics Co., Ltd: Overall Product Portfolio
Figure 7.16: Beijing Genomics Institute (BGI) Genomics Co., Ltd: Overall Financials, 2017-2018
Figure 7.17: Beijing Genomics Institute (BGI) Genomics Co., Ltd: Revenue (by Segment), 2017-2018
Figure 7.18: Beijing Genomics Institute (BGI) Genomics Co., Ltd: Revenue (by Region), 2017-2018
Figure 7.19: Beijing Genomics Institute (BGI) Genomics Co., Ltd: R&D Expenditure, 2017-2018
Figure 7.20: Beijing Genomics Institute (BGI) Genomics Co., Ltd: SWOT Analysis
Figure 7.21: Danaher Corporation: Overall Product Portfolio
Figure 7.22: Danaher Corporation: Overall Financials, 2016-2018
Figure 7.23: Danaher Corporation: Revenue (by Business Segment), 2016-2018
Figure 7.24: Danaher Corporation: Revenue (by Region), 2016-2018
Figure 7.25: Danaher Corporation: R&D Expenditure, 2016-2018
Figure 7.26: Danaher Corporation: SWOT Analysis
Figure 7.27: DiaCarta Inc.: Overall Product Portfolio
Figure 7.28: DiaCarta Inc.: SWOT Analysis
Figure 7.29: F. Hoffmann-La Roche Ltd: Overall Product Portfolio
Figure 7.30: F. Hoffmann-La Roche Ltd: Overall Financials, 2016-2018
Figure 7.31: F. Hoffmann-La Roche Ltd: Revenue (by Segment), 2016-2018
Figure 7.32: F. Hoffmann-La Roche Ltd: Revenue Split for Diagnostics, 2016-2018
Figure 7.33: F. Hoffmann-La Roche Ltd: Revenue (by Region), 2016-2018
Figure 7.34: F. Hoffmann-La Roche Ltd: R&D Expenditure, 2016-2018
Figure 7.35: F. Hoffmann-La Roche Ltd: SWOT Analysis
Figure 7.36: Illumina, Inc.: Overall Product Portfolio
Figure 7.37: Illumina, Inc.: Overall Financials, 2016-2018
Figure 7.38: Illumina, Inc.: Revenue (by Segment), 2016-2018
Figure 7.39: Illumina, Inc.: Revenue (by Region), 2016-2018
Figure 7.40: Illumina, Inc.: R&D Expenditure, 2016-2018
Figure 7.41: Illumina, Inc.: SWOT Analysis
Figure 7.42: Novogene Corporation: Overall Product Portfolio
Figure 7.43: Novogene Corporation: SWOT Analysis
Figure 7.44: PerkinElmer, Inc.: Overall Product Portfolio
Figure 7.45: Perkin Elmer, Inc.: Overall Financials, (2016-2018)
Figure 7.46: Perkin Elmer, Inc.: Revenue (by Business Segment), 2016-2018
Figure 7.47: Perkin Elmer, Inc.: Revenue (by Region), 2016-2018
Figure 7.48: PerkinElmer, Inc.: R&D Expenditure, 2016-2018
Figure 7.49: PerkinElmer, Inc.: SWOT Analysis
Figure 7.50: Shanghai Fosun Pharmaceutical (Group) Co., Ltd.: Overall Product Portfolio
Figure 7.51: Shanghai Fosun Pharmaceutical (Group) Co., Ltd.: Overall Financials, 2016-2018
Figure 7.52: Shanghai Fosun Pharmaceutical (Group) Co., Ltd.: Revenue (by Business Segment), 2016-2018
Figure 7.53: Shanghai Fosun Pharmaceutical (Group) Co., Ltd.: Revenue (by Region), 2016-2018
Figure 7.54: Shanghai Fosun Pharmaceutical (Group) Co., Ltd.: R&D Expenditure, 2016-2018
Figure 7.55: Shanghai Fosun Pharmaceutical (Group) Co., Ltd.: SWOT Analysis
Figure 7.56: Shuwen Biotech Co. Ltd.: Overall Product Portfolio
Figure 7.57: Shuwen Biotech Co. Ltd.: SWOT Analysis
Figure 7.58: Thermo Fisher Scientific Inc.: Overall Product Portfolio
Figure 7.59: Thermo Fisher Scientific Inc.: Overall Financials, 2016-2018
Figure 7.60: Thermo Fisher Scientific Inc.: Revenue (by Segment), 2016-2018
Figure 7.61: Thermo Fisher Scientific Inc.: Revenue (by Region), 2016-2018
Figure 7.62: Thermo Fisher Scientific Inc.: R&D Expenditure, 2016-2018
Figure 7.63: Thermo Fisher Scientific Inc.: SWOT Analysis
Figure 7.64: WuXi AppTec Co., Ltd.: Overall Product Portfolio
Figure 7.65: WuXi AppTec Co., Ltd.: Overall Financials, 2017-2018
Figure 7.66: WuXi AppTec Co., Ltd.: Revenue (by Segment), 2017-2018
Figure 7.67: WuXi AppTec Co., Ltd.: Revenue (by Region), 2017-2018
Figure 7.68: WuXi AppTec Co., Ltd.: R&D Expenditure, 2016-2018
Figure 7.69: WuXi AppTec Co., Ltd.: SWOT Analysis
Figure 7.70: Xiamen Aide Biomedical Technology Co., Ltd.: Overall Product Portfolio
Figure 7.71: Xiamen Aide Biomedical Technology Co., Ltd.: Overall Financials, 2016-2017
Figure 7.72: Xiamen Aide Biomedical Technology Co., Ltd.: Revenue (by Segment), 2016-2017
Figure 7.73: Xiamen Aide Biomedical Technology Co., Ltd.: Revenue (by Region), 2016-2017
Figure 7.74: Xiamen Aide Biomedical Technology Co., Ltd.: R&D Expenditure, 2016-2017
Figure 7.75: Xiamen Aide Biomedical Technology Co., Ltd.: SWOT Analysis
Figure 7.76: Chengdu 23Mofang Biotechnology Co., Ltd.: Overall Product Portfolio
Figure 7.77: iCarbonX Group Limited: Overall Product Portfolio
Figure 7.78: WeGene: Overall Product Portfolio
Figure 8.1: China Precision Medicine Market Segmentation
Figure 8.2: China Precision Medicine Market Research Methodology
Figure 8.3: Primary Research
Figure 8.4: Secondary Research
Figure 8.5: Data Triangulation
Figure 8.6: Bottom-up Approach (Segment-wise Analysis)
Figure 8.7: Top-down Approach (Segment-wise Analysis)
Figure 8.8: Assumptions and Limitations
Figure 8.9: Considered Factors for Data Prediction and Modeling